Baudax Bio Inc
OTC:BXRXQ

Watchlist Manager
Baudax Bio Inc Logo
Baudax Bio Inc
OTC:BXRXQ
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 44 USD

Profitability Summary

Baudax Bio Inc's profitability score is 9/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

9/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

9/100
Profitability
Score
9/100
Profitability
Score

Margins

Earnings Waterfall
Baudax Bio Inc

Margins Comparison
Baudax Bio Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Baudax Bio Inc
OTC:BXRXQ
44 USD
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277.8B CHF
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.8B CHF
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
213.9B USD
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Baudax Bio Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Baudax Bio Inc
OTC:BXRXQ
44 USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277.8B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
217.9B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.8B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
213.9B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Baudax Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate